Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m).
Following the acquisition, Trinity Pharma’s management will continue as minority partner, running the business under the supervision of Strides Pharma Asia.
Go deeper with GlobalData
“GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia.”
Strides Pharma Asia is a Singaporean pharmaceutical company and a subsidiary of Strides Shasun. The acquisition will enable the company to establish its presence in South Africa.
GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia (GSAL) increasing its total stake to 75%.
The acquisition will enable the UK-based pharmaceutical company to expand its presence in Saudi Arabia.
